title: Biosafety data as confidential business information.
abstract: Removal of confidentiality claims on biosafety data is necessary to adhere to standard scientific procedures of quality assurance, to increase transparency, to minimize impacts of conflicts of interests, and ultimately to improve public confidence in GMOs.
authors.affiliation: Department of Pharmacy, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway. kaare.nielsen@uit.no
authors.forename: Kaare M
authors.initials: KM
authors.lastname: Nielsen
mesh_terms: D003132:Commerce; D003219:Confidentiality; D012449:Safety